News
8h
TipRanks on MSNElicio Therapeutics Publishes Promising Phase 1 Study DataElicio Therapeutics ( (ELTX) ) just unveiled an announcement. On August 12, 2025, Elicio Therapeutics announced the publication of follow-up data from its Phase 1 AMPLIFY-201 study in Nature Medicine ...
The Telangana Council of Higher Education (TGCHE) has announced the Telangana State Education Common Entrance Test (TS/TG ...
Developments announced thecompletion of its Phase I drilling campaign to support the conversion of a portion of its current Indicated ...
Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to ...
IO Biotech's phase 3 melanoma trial showed a strong PFS benefit, especially in true 1st-line and PD1-negative patients. Click ...
One thousand dollars invested three years ago is now worth an incredible $10,640 as of Aug. 11. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...
The Lagos State Government has sealed Dowen College, located in Lekki Phase 1, after waste materials linked to the school ...
Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...
Company reports Q2 2025 AUCATZYL® net product revenue of $20.9 million and $29.9 for the first six months of 2025Company recently received conditional marketing authorization from U.K. Medicines and ...
The 11.65 km long metro line will connect the East part to the West Lucknow from Charbagh to Vasant Kunj. The project is scheduled to be completed in five years. It will be implemented by the Uttar ...
MoonLake Immunotherapeutics remains a promising clinical-stage biotech, with potentially its first FDA approval in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results